The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Sunil Reddy
Medical oncologist, Cutaneous oncology specialist
Clinical Assistant Professor, Medicine - Oncology
- 900 Blake Wilbur Drive
- 3rd Floor
- Palo Alto, CA 94304
- Phone: 650-498-6000
- 875 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-498-6000
Practice Areas
Professional Education
- Board Certification: Medical Oncology, American Board of Internal Medicine (2003)
- Fellowship: Stanford University School of Medicine (2000) CA
- Residency: University of Michigan (1997) MI
- Internship: University of Michigan Hospital (1995) MI
- Medical Education: UCI College of Medicine (1994) CA
Publications
-
A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
Duvic, M., Reddy, S. A., Pinter-Brown, L., Korman, N. J., Zic, J., & Kim, Y. H. (2009). A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders. CLINICAL CANCER RESEARCH, 15(19), 6217-6224. -
Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome
Woo, D. K., Jones, C. R., Vanoli-Storz, M. N., Kohler, S., Reddy, S., & Kim, Y. H. (2009). Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome. ARCHIVES OF DERMATOLOGY, 145(6), 667-674. -
Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab
Morales, A. V., Advani, R., Horwitz, S. M., Riaz, N., Reddy, S., & Kim, Y. H. (2008). Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(6), 953-957. -
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study
McCormick, A. A., Reddy, S., Reinl, S. J., Cameron, T. I., Czerwinkski, D. K., & Levy, R. (2008). Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(29), 10131-10136.
-
Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas
Reddy, S. A., & Levy, R. (2004). Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas. BRITISH JOURNAL OF HAEMATOLOGY, 124(5), 626-628.
-
CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
Liu, H. L., Hoppe, R. T., Kohler, S., Harvell, J. D., Reddy, S., & Kim, Y. H. (2003). CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 49(6), 1049-1058.
-
T cell antigen receptor vaccines for active therapy of T cell malignancies
Reddy, S. A., Okada, C., Wong, C., Bahler, D., & Levy, R. (2001). T cell antigen receptor vaccines for active therapy of T cell malignancies. CUTANEOUS T CELL LYMPHOMA: BASIC AND CLINICALLY RELEVANT BIOLOGY, 941, 97-105.
-
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells
Stockerl-Goldstein, K. E., Reddy, S. A., Horning, S. J., Blume, K. G., Chao, N. J., & Negrin, R. S. (2000). Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(5), 506-512.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Sep 2015
The entire team, NP, PA & MD are all the best I could hope for, and I am fortunate to have them.
SHC Patient, Jul 2015
Dr. Kipp Weis kept was excellent - saw me first. dr. Reddy was outstanding.
SHC Patient, Jul 2015
I feel he has not informed me well enough as to what's happening, his concerns on explanations. I feel like I'm flying blind!!
SHC Patient, Jul 2015
I have recommended this provider to several people.
SHC Patient, May 2015
Good.
SHC Patient, Apr 2015
I have recommended him.
SHC Patient, Mar 2015
Dr. Reddy has been like a primary care physician. Very good.
SHC Patient, Mar 2015
Dr. Reddy is outstanding! His care and concern and availability dealing with my stage 4 melanoma problems are a great help.
SHC Patient, Feb 2015
Dr. Reddy is trying to do everything he can to save my life. I'm so grateful to have him as my dr.
SHC Patient, Jan 2015
Dr. Reddy is a caring hands on doctor who spends time knowing all issues of my cancer and provides me with excellent personalized service.
SHC Patient, Jan 2015
Provider seemed perfunctory and no follow-up.
SHC Patient, Jul 2014
Dr. Reddy and the PA spent an incredible amount of time with me.
SHC Patient, Jul 2014
Dr. Reddy - excellent doctor.
SHC Patient, Jun 2014
1 hr. w/me.
SHC Patient, Feb 2014
Dr. Reddy and David Nguyen spent a TON of time answering all our questions about cancer treatment. Very patient and thorough.
SHC Patient, Sep 2015
The entire team, NP, PA & MD are all the best I could hope for, and I am fortunate to have them.
SHC Patient, Jul 2015
Dr. Kipp Weis kept was excellent - saw me first. dr. Reddy was outstanding.
SHC Patient, Jul 2015
I feel he has not informed me well enough as to what's happening, his concerns on explanations. I feel like I'm flying blind!!
SHC Patient, Jul 2015
I have recommended this provider to several people.
SHC Patient, May 2015
Good.
SHC Patient, Apr 2015
I have recommended him.
SHC Patient, Mar 2015
Dr. Reddy has been like a primary care physician. Very good.
SHC Patient, Mar 2015
Dr. Reddy is outstanding! His care and concern and availability dealing with my stage 4 melanoma problems are a great help.
SHC Patient, Feb 2015
Dr. Reddy is trying to do everything he can to save my life. I'm so grateful to have him as my dr.
SHC Patient, Jan 2015
Dr. Reddy is a caring hands on doctor who spends time knowing all issues of my cancer and provides me with excellent personalized service.
SHC Patient, Jan 2015
Provider seemed perfunctory and no follow-up.
SHC Patient, Jul 2014
Dr. Reddy and the PA spent an incredible amount of time with me.
View All 15 Patient Comments »